Description
GDC-6036 is a KRAS G12C covalent inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
GDC-6036 is a KRAS G12C covalent inhibitor.
| Cas No. | 2417987-45-0 |
|---|---|
| Purity | ≥98% |
| Formula | C29H32ClF4N7O2 |
| Formula Wt. | 622.07 |
| IUPAC Name | 1-[(3S)-4-[7-[6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl]-6-chloro-8-fluoro-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]quinazolin-4-yl]-3-methylpiperazin-1-yl]prop-2-en-1-one |
| Synonym | GDC6036 |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Cascetta P, Marinello A, Lazzari C, et al. KRAS in NSCLC: state of the art and future perspectives. Cancers (Basel). 2022 Nov 4;14(21):5430. PMID: 36358848
c-MET inhibitor.
Endogenous peptide, involved in hormone regulat...
Derivative of methyl caffeate, hydroxycinnamic ...
Topoisomerase II inhibitor, RPA modulator.
Endogenous glycoprotein; lactoferrin agonist.
Endogenous opioid peptide; μOR agonist.
Folic acid derivative
Saponin found in Polygala.
Mineralocorticoid, aldosterone, AR antagonist, ...
Polyether Ca2+ ionophore.
Natriuretic, vasodilatory peptide fragment; B1/...
Calcium channel blocker.
Tretinoin analog; RARα/β/γ agonist.
Geldanamycin derivative; HSP90 inhibitor.
Penciclovir prodrug, nucleoside (guanosine) ana...
LRRK2 inhibitor.
Nucleotide analog; RT inhibitor.
Mast cell stabilizer; histamine H1/2/3 antagoni...
NSAID; COX-2 inhibitor.
B-Raf and c-Raf inhibitor.